膀胱部分切除术与根治性全膀胱切除术治疗局限性肌层浸润性膀胱癌的临床分析

余昆; 代林; 刘胜; 余志海; 李风; 刘美平; 石国忠; 夏宗禹

doi:10.16016/j.1000-5404.201708212

您当前的位置：

首页 >

文章列表页 >

膀胱部分切除术与根治性全膀胱切除术治疗局限性肌层浸润性膀胱癌的临床分析

临床医学 | 更新时间：2026-01-09

- 膀胱部分切除术与根治性全膀胱切除术治疗局限性肌层浸润性膀胱癌的临床分析
- Comparison of therapeutic effects of partial cystectomy versus radical cystectomy for localized muscle invasive bladder cancer
- 第三军医大学学报 2018年40卷第2期页码：169-175
- 作者机构：
  
  1.404000 重庆, 重庆三峡中心医院泌尿外科
  2.404600 重庆，重庆市奉节县中医院外科
- 作者简介：
  
  [ 刘胜，E-mail: 15923837017@163.com LIU Sheng, E-mail: 15923837017@163.com
- 基金信息：
- DOI：10.16016/j.1000-5404.201708212
  中图分类号： R615;R699.5
- 收稿：2017-08-31，
  
  修回：2017-10-25，
  
  纸质出版：2018-01-30
- 稿件说明：
移动端阅览
余昆, 代林, 刘胜, 等. 膀胱部分切除术与根治性全膀胱切除术治疗局限性肌层浸润性膀胱癌的临床分析[J]. 第三军医大学学报, 2018,40(2):169-175.

Kun YU, Lin DAI, Sheng LIU, et al. Comparison of therapeutic effects of partial cystectomy versus radical cystectomy for localized muscle invasive bladder cancer[J]. Journal of Third Military Medical University, 2018, 40(2): 169-175.
余昆, 代林, 刘胜, 等. 膀胱部分切除术与根治性全膀胱切除术治疗局限性肌层浸润性膀胱癌的临床分析[J]. 第三军医大学学报, 2018,40(2):169-175. DOI： 10.16016/j.1000-5404.201708212.

Kun YU, Lin DAI, Sheng LIU, et al. Comparison of therapeutic effects of partial cystectomy versus radical cystectomy for localized muscle invasive bladder cancer[J]. Journal of Third Military Medical University, 2018, 40(2): 169-175. DOI： 10.16016/j.1000-5404.201708212.

摘要

目的

比较膀胱部分切除术(partial cystectomy，PC)与根治性全膀胱切除术(radical cystectomy，RC)治疗局限性肌层浸润性膀胱癌(muscle-invasive bladder cancer，MIBC)的疗效。

方法

回顾性分析2007年12月至2012年3月本院收治的83例肌层浸润性膀胱癌患者，根据治疗方案的不同分为PC组与RC组。PC组患者采用PC+术后给予吉西他滨联合顺铂(GC)的全身化疗和膀胱灌注羟基喜树碱治疗; RC组患者接受RC+盆腔淋巴结清扫。对出院后患者进行随访，记录围手术期并发症发生情况、术后化疗不良反应并进行统计分析。采用Kaplan-Meier法比较两种术式患者5年总生存率(OS)、5年癌特异性生存率(CSS)的差异。

结果

经过4~60个月的随访(中位随访时间34个月)，PC组围手术期并发症总发生率为6.38%，RC组为22.2%，两组患者并发症发生率差异有统计学意义(

=4.449，

=0.035)。PC组术后5年随访期内出现17例局部复发，复发率为36.2%;RC组随访期间局部复发9例，复发率为25.0%。两组患者复发率差异无统计学意义(

=1.182，

=0.277)。PC组随访期间死亡18例，死亡率为38.3%，其中13例死于膀胱癌全身转移。RC组死亡15例，死亡率为41.7%，其中9例死于膀胱癌复发并全身转移。采用Kaplan-Meier曲线对两组患者生存状况进行分析，PC组与RC组患者5年总生存率、5年癌特异性生存率分别为61.7%与58.3%、72.3%与75.0%，差异均无统计学意义(

0.05)。

结论

PC配合辅助化疗治疗局限性MIBC具有与RC相似的效果，是一种疗效确切、并发症发生率低、手术安全性高且操作相对简单的保留膀胱的手术。

Abstract

Objective

To compare the therapeutic effects of partial cystectomy (PC) combined with chemotherapy

radical cystectomy (RC) for treatment of localized muscle-invasive bladder cancer (MIBC).

Methods

A retrospective analysis was conducted among patients receiving surgeries for localized MIBC in our hospital between December

2007 and March

2012. According to the treatment plans

the patients were divided into PC group (47 patients) and RC group (36 patients). In PC group

the patients received PC combined with postoperative systemic chemotherapy (gemcitabine combined with cisplatin) and bladder perfusion chemotherapy with hydroxycamptothecin

and those in RC group received RP with pelvic lymph node dissection. The patients were followed up for perioperative complications and adverse effects of postoperative chemotherapy

and their 5-year overall survival (OS) and 5-year cancer-specific survival (CSS) were analyzed by Kaplan-Meier analysis.

Results

During the follow-up for 4 to 60 months (median 34 months)

perioperative complications occurred in 6.38% of the patients in PC group

a rate significantly lower than that of 22.2% in RC group (

Chi

-squore=4.449

=0.035). Postoperative recurrence occurred in 17 (36.2%) patients in PC group during the 5-year follow up

as compared with 9 (25.0%) in RC group (

Chi

-squore=1.182

=0.277). During the follow-up

death occurred in 18 (38.3%) cases in PC group

including 13 cases due to bladder cancer metastasis; death occurred in 15 (41.7%) cases in RC group

including 9 cases due to cancer metastasis. The 5-year OS and CSS were 61.7% and 72.3% in PC group and were 58.3% and 75.0% in RC group

respectively

showing no significant differences between the 2 groups (

0.05).

Conclusion

Partial resection of the bladder with adjuvant chemotherapy has a similar effect to radical cystectomy for treatment of localized MIBC

but partial resection is associated with a lower incidence of complications

better surgical safety and simpler operations for preserving the bladder.

关键词

Keywords

references

吴毅, 肖英明, 李曾, 等.根治性膀胱切除术围手术期并发症分析[J].四川医学, 2017, 38(2): 219-222.DOI: 10.16252/j.cnki.issn1004-0501-2017.02.028.

WU Y, XIAO Y M, LI Z, et al .Analysis of perioperative complications of radical resection of bladder[J ] .Sichuan Med J, 2017, 38(2): 219-222.DOI: 10.16252/j.cnki.issn1004-0501-2017.02.028.

RESNICK M I, JR V J O.Segmental Resection for Carcinoma of the Bladder: Review of 102 Patients[J].J Urol, 1973, 109(6): 1007-1010.

KNOEDLER J J, BOORJIAN S A, KIN S P, et al .Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis[J ] .J Urol, 2012, 188(4): 1115-1119.DOI: 10.1016/j.juro.2012.06.029.

KOGA F, KIHARA K, YOSHIDA S, et al .Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients[J ] .BJU Int, 2012, 109(6): 860-866.DOI: 10.1111/j.1464-410X.2011.10425.x.

王平, 沈思瑶, 薄隽杰, 等.膀胱部分切除术联合化疗治疗肌层浸润性膀胱癌的临床疗效分析[J].中国癌症杂志, 2012, 22(10): 766-769.DOI: 10.3969/j.issn.1007-3969.2012.10.009.

WANG P, SHEN S Y, BO J J, et al .Clinical study of partial cystectomy combined with chemotherapy for muscle-invasive bladder cancer[J ] .Chin Oncol, 2012, 22(10): 766-769.DOI: 10.3969/j.issn.1007-3969.2012.10.009.

范欣荣, 李汉忠, 纪志刚, 等.保留器官的综合治疗——膀胱癌治疗的新模式(附107例报告)[J].中华泌尿外科杂志, 2016, 37(2): 131-134.DOI: 10.3760/cma.j.issn.1000-6702.2016.02.017.

FAN X R, LI H Z, JI Z G et al .Organ preservation treatment of bladder cancer-a new model by trimodality (107 cases report)[J ] .Chin J Urol, 2016, 37(2): 131-134.DOI: 10.3760/cma.j.issn.1000-6702.2016.02.017.

SMITH Z L, CHRISTODOULEAS J P, KEEFE S M, et al .Bladder preservation in the treatment of muscle-invasive bladder cancer(MIBC): a review of the li terature and a practical approach to therapy[J ] .BJU Int, 2013, 112(1): 13-25.DOI: 10.1111/j.1464-410X.2012.11762.x.

梅延辉, 张冰, 燕东亮等.腹腔镜下膀胱全切除前后施行盆腔淋巴结清扫术疗效对比[J].现代泌尿外科杂志, 2016, 21(10): 782-785.DOI: 10.3969/j.issn.1009-8291.2016.10.011.

MEI Y H, ZHANG B, YAN D L, et al .Comparison of the efficacy of performing pelvic lymph node dissection before versus after laparoscopic radical cystectomy[J ] .J Mod Urol, 2016, 21(10): 782-785.DOI: 10.3969/j.issn.1009-8291.2016.10.011.

毛士玉, 黄天宝, 熊大波等.膀胱全切Bricker术与Studer原位膀胱术8年的随访和评价[J].现代泌尿外科杂志, 2016, 21(3):170-173.DOI: 10.3969/j.issn.1009-8291.2016.03.003.

MAO S Y, HUANG T B, XIONG D B, et al .Bricker conduit and studer orthotopic ileal neobladder after radical cystectomy: 8-year follow-up and evaluation[J ] .J Mod Urol, 2016, 21(3): 170-173.DOI: 10.3969/j.issn.1009-8291.2016.03.003.

那彦群, 叶章群, 孙颖浩.中国泌尿外科疾病诊断治疗指南手册(2014版)[M].北京:人民卫生出版社, 2014:43-44.

NA Y Q, YE Z Q, SUN Y H, et al .Handbook of disease diagnosis and treatment for Department of Urology in China (2014 Edition)[M ] .Beijing: People's Health Publishing House, 2014: 43-44.

黄健, 刘皓, 林天歆, 等.腹腔镜下根治性膀胱切除术现状及展望:十年经验总结及文献进系统分析[J].中华泌尿外科杂志, 2012, 33(11): 805-809.DOI: 10.3760/cma.j.issn.1000-6702.2012.11.001.

HUANG J, LIU H, LIN T X, et al .Current status and Prospect of laparoscopic radical cystectomy: a ten year experience and systematic review of literature[J ] .Chin J Urol, 2012, 33(11): 805-809.DOI: 10.3760/cma.j.issn.1000-6702.2012.11.001.

Ikeda M, Matsumoto K, Nishi M, et al .Comparison of radical cystectomy and chemoradiotherapy in patients with locally advanced bladder cancer[J ] .Asian Pac J Cancer Prev, 2014, 15 (16): 6519-6524.DOI: 10.7314/apjcp.2014.15.16.6519.

李信, 王明, 何卫阳, 等.膀胱全切不同尿流改道术后生活质量的比较[J].重庆医科大学学报, 2016, 41(2): 201-204.DOI: 10.13406/j.cnki.cyxb.000809.

LI X, WANG M, HE W Y, et al .Comparison of quality of life after cystectomy and different urinary diversions for bladder cancer[J ] .J Chongqing Med Univ, 2016, 41(2): 201-204.DOI: 10.13406/j.cnki.cyxb.000809.

MAK R H, HUNT D, SHIPLEY W U, et al .Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233[J ] .J Clin Oncol, 2014, 32(34): 3801-3809.DOI: 10.1200/JCO.2014.57.5548.

PATEL M N, HEMAL A K.Molecular targeted fluorescence-guided intraoperative imaging of bladder cancer nodal drainage using indocyanine green during radical and partial cystectomy[J].Curr Urol Rep, 2016, 17(10): 74.DOI: 10.1007/s11934-016-0633-z.

李哲, 魏素菊, 刘风玲.循环肿瘤细胞监测早期膀胱癌微转移的价值[J].肿瘤防治研究, 2015, 42(7): 740-742.DOI: 10.3971/j.issn.1000-8578.2015.07.021.

LI Z, WEI S J, LIU F L.Value of circulating tumor cells in early monitoring of bladder cancer micrometastases[J].Cancer Res Prev Treat, 2015, 42(7): 740-742.DOI: 10.3971/j.issn.1000-8578.2015.07.021.

李涛魏, 乔红, 傅崇德, 等.新辅助化疗甲氨蝶呤、长春碱、阿霉素、顺铂方案与吉西他滨、顺铂方案治疗肌层浸润性膀胱癌疗效比较的荟萃分析[J].中华泌尿外科杂志, 2016, 37(11): 813-818.DOI: 10.3760/cma.j.issn.1000-6702.2016.11.006.

LI T W, QIAO H, FU C D, et al .Neoadjuvant chemotherapy with methotrexate/vinblastine/doxorubicin/cisplatin vs.gemcitabine/cisplatin for muscle-invasive bladder cancer: a review and meta-analysis[J ] .Chin J Urol, 2016, 37(11): 813-818.DOI: 10.3760/cma.j.issn.1000-6702.2016.11.006.

ZARGAR H, ALMASSI N, KOVAC E, et al .Change in psoas muscle volume as a predictor of outcomes in patients treated with chemotherapy and radical cystectomy for muscle-invasive bladder cancer[J ] .Bladder Cancer, 2017, 3(1): 57-63.DOI: 10.3233/blc-160080.

PIET A H, HULSHOF M C, PIETERS B R, et al .Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer[J ] .Strahlenther Onkol, 2008, 184(6): 313-318.DOI: 10.1007/s00066-008-1797-3.

VON RUNDSTEDT F C, MATA D A, KRYVENKO O N, et al .Utility of clinical risk stratification in the selection of muscle-invasive bladder cancer patients for neoadjuvant chemotherapy: a retrospective cohort study[J ] .Bladder Cancer, 2017, 3(1): 35-44. DOI:10.3233/blc-160062.

Capitanio u, Isbarn H, Shariat S F, et al .Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder:a population-based matched analysist[J ] .Urology, 2009, 74(4): 858-864. DOI: 10.1016/j.urology.2009.03.052.

CLARK P E, SPIESS P E, AGARWAL N, et al .NCCN Guidelines insights: bladder cancer, version 2.2016[J ] .J Nat Compr Canc Netw, 2016, 14(10): 1213.

曹志, 张国辉, 李志辉.保留膀胱的综合治疗与根治性手术治疗肌层浸润性膀胱癌预后的荟萃分析[J].癌症进展, 2016, 14(2): 106-108. DOI: 10.11877/j.issn.1672-1535.2016.14.02.04.

CAO Z, ZHANG G H, LI Z H.A meta-analysis of the prognosis of comprehensive bladder preservation surgery and radical cystectomy for muscle-invasive bladder cancer[J].Oncol Prog, 2016, 14(2): 106-108.DOI: 10.11877/j.issn.1672-1535.2016.14.02.04.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

免疫治疗联合靶向治疗及化疗在微卫星稳定型转移性结直肠癌患者三线治疗中的疗效和安全性

肺腺癌A549细胞中TNIK通过Rho/ROCK/LIMK1调控微丝骨架形态

氧化铱纳米载药复合物的制备及其用于肿瘤声动力-化疗协同治疗的研究

118例视网膜母细胞瘤临床治疗分析

辣椒碱抑制分化因子1表达以及核转移提高骨肉瘤对顺铂敏感性